10.07.2015 Views

Proceedings book download - 5Z.com

Proceedings book download - 5Z.com

Proceedings book download - 5Z.com

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Proceedings</strong> of the 31 st European Peptide SymposiumMichal Lebl, Morten Meldal, Knud J. Jensen, Thomas Hoeg-Jensen (Editors)European Peptide Society, 2010H β2ORH β3NHCD and Fluorescence Screening of α-Synuclein-PeptideInteractionsAnna Marchiani 1 , Giada Massalongo 1 , Stefano Mammi 1 , IsabellaTessari 2 , Luigi Bubacco 2 , Andrea Calderan 1 , and Paolo Ruzza 11 Institute of Biomolecular Chemistry of CNR, Padova Unit, and Department of ChemicalSciences, University of Padova, Padova, 35131, Italy; 2 Department of Biology,University of Padova, Padova, 35131, ItalyIntroductionα-Synuclein (AS) is the major <strong>com</strong>ponent of the intracellular protein-aggregates found inthe dopaminergic neurons of Parkinson's disease patients.A critical step in the aggregation of AS is the production of oligomers, which are morecytotoxic than the amyloid-like fibrils. Aggregation inhibitors are expected to reduce AScytotoxicity by preventing oligomer formation; on the other hand, an aggregationaccelerator has recently been reported to reduce AS cytotoxicity [1], likely by causingoligomer precipitation. Therefore, ligands that modulate amyloid aggregation may have atherapeutic potential. For this purpose, we synthesized two peptides [2,3], named BB1 andBB2, respectively, and their all-D amino acid analogues as potential amyloid aggregationmodulating ligands. In addition, a rotamer-scan of the Phe4 residue into the BB1 peptidewas performed with the aim to evaluate the influence of the topography of this residue inthe binding process.Constraint-producing amino acid substitutions are typically used as modifier of thepeptide/residue topography. The Tic residue is characterized by only two allowedside-chain orientations, the g(-) or g(+) conformations (Figure 1). The preferred conformationof the D-Tic residue into peptideHNHR 1L-PheH αRORH β3ONHR 1L-TicRNHgauche (-) trans gauche (+)OH αH β2RCH 3NHRR 1OOL-NMePheFig. 1. Structure of constrained analoguesof Phe and staggered side-chainconformers.H β2NHH αH β3chain is g(-), which corresponds to g(+) foran L-residue in the same position [4].For the L-NMePhe residue, all threeside-chain conformations are possible inprinciple, but mostly the t and g(-)conformations are observed in peptides(Figure 1) [5]. The presence of a methylgroup on the nitrogen constrains the ψ angleof the preceding residue to a large valuetypical of those found in extended orβ-structures.In addition to providing topographyrestrictions, constraint residues can impartother properties to peptides, such as increasedresistance to proteolysis.Results and DiscussionPeptides were synthesized by manual SPPS on Rink-amide resin. HBTU/HOBt activationemployed a three-fold molar excess of Fmoc-amino acids in DMF solution for eachcoupling cycle. Coupling to the secondary amino group of constrained residues wasperformed using HATU as the coupling reagent. Deprotection was performed with 20%piperidine. Cleavage from the resin and deprotection were performed by treatment withTFA-anisole-TIS-H 2 O (95:2.5:2.0:0.5 v/v). Peptides were purified by preparativeRP-HPLC and the molecular weights were checked by ESI-MS.Binding of BB1-peptides to AS was monitored by changes in Trp fluorescenceemission (Figure 2A). Peptides (1.5 µM) in 20 mM phosphate buffer, pH 6.8, at 25 °C weretitrated with small aliquots of AS (65.9 µM) with minimal dilution. Peptide fluorescenceemissions were recorded using an excitation wavelength of 295 nm. Binding constantswere estimated from the titration data using a nonlinear least-squares <strong>com</strong>puter fit to theequation based on 1:1 binding stoichiometry [6].Far-UV CD analysis was used both to determine the binding of BB2-peptides to ASand to evaluate the influence of peptide interactions on AS conformation (Figure 2B).332

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!